JP2004138610A5 - - Google Patents

Download PDF

Info

Publication number
JP2004138610A5
JP2004138610A5 JP2003334210A JP2003334210A JP2004138610A5 JP 2004138610 A5 JP2004138610 A5 JP 2004138610A5 JP 2003334210 A JP2003334210 A JP 2003334210A JP 2003334210 A JP2003334210 A JP 2003334210A JP 2004138610 A5 JP2004138610 A5 JP 2004138610A5
Authority
JP
Japan
Prior art keywords
antibody
pro245
polypeptide
pro245 polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003334210A
Other languages
English (en)
Japanese (ja)
Other versions
JP4040004B2 (ja
JP2004138610A (ja
Filing date
Publication date
Priority claimed from PCT/US1998/019437 external-priority patent/WO1999014241A2/en
Application filed filed Critical
Publication of JP2004138610A publication Critical patent/JP2004138610A/ja
Publication of JP2004138610A5 publication Critical patent/JP2004138610A5/ja
Application granted granted Critical
Publication of JP4040004B2 publication Critical patent/JP4040004B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003334210A 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用 Expired - Fee Related JP4040004B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6636497P 1997-11-21 1997-11-21
US7893698P 1998-03-20 1998-03-20
PCT/US1998/019437 WO1999014241A2 (en) 1997-09-17 1998-09-17 Compositions and methods for the treatment of immune related diseases

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000522240A Division JP3497133B2 (ja) 1997-11-21 1998-11-20 Ａ−３３関連抗原およびそれらの薬理学的使用

Publications (3)

Publication Number Publication Date
JP2004138610A JP2004138610A (ja) 2004-05-13
JP2004138610A5 true JP2004138610A5 (https=) 2005-06-09
JP4040004B2 JP4040004B2 (ja) 2008-01-30

Family

ID=38175777

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000522240A Expired - Fee Related JP3497133B2 (ja) 1997-11-21 1998-11-20 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2003334209A Expired - Fee Related JP3950097B2 (ja) 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2003334210A Expired - Fee Related JP4040004B2 (ja) 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2007056461A Expired - Lifetime JP4382827B2 (ja) 1997-11-21 2007-03-06 Ａ−３３関連抗原およびそれらの薬理学的使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2000522240A Expired - Fee Related JP3497133B2 (ja) 1997-11-21 1998-11-20 Ａ−３３関連抗原およびそれらの薬理学的使用
JP2003334209A Expired - Fee Related JP3950097B2 (ja) 1997-11-21 2003-09-25 Ａ−３３関連抗原およびそれらの薬理学的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007056461A Expired - Lifetime JP4382827B2 (ja) 1997-11-21 2007-03-06 Ａ−３３関連抗原およびそれらの薬理学的使用

Country Status (11)

Country Link
EP (3) EP2014677A1 (https=)
JP (4) JP3497133B2 (https=)
AT (3) ATE393786T1 (https=)
AU (1) AU735081B2 (https=)
CA (1) CA2309358A1 (https=)
CY (1) CY1108212T1 (https=)
DE (3) DE69839430T2 (https=)
DK (2) DK1481990T3 (https=)
ES (3) ES2288649T3 (https=)
PT (2) PT1481990E (https=)
WO (1) WO1999027098A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019991A1 (en) * 1999-09-15 2001-03-22 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6951924B2 (en) 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
US7968689B2 (en) * 1997-03-07 2011-06-28 Human Genome Sciences, Inc. Antibodies to HSDEK49 polypeptides
US6878806B2 (en) 1997-03-14 2005-04-12 Human Genome Sciences, Inc. Human secreted protein HTEEB42
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US7192589B2 (en) * 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
CA2343006A1 (en) * 1998-09-17 2000-03-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP4897690B2 (ja) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド 補体関連障害の予防および処置のためのＣＲＩｇポリペプチド
EP3299027A1 (en) 2005-11-04 2018-03-28 Genentech, Inc. Use of complement pathway inhibitors to treat ocular diseases
CN106188303A (zh) 2006-11-02 2016-12-07 健泰科生物技术公司 人源化的抗‑d因子抗体
AR066660A1 (es) 2007-05-23 2009-09-02 Genentech Inc Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
RU2553517C2 (ru) 2008-05-06 2015-06-20 Дженентек, Инк. Варианты crig с созревшей аффинностью
AU2014306867B2 (en) 2013-08-12 2017-10-26 Genentech, Inc. Compositions and method for treating complement-associated conditions
EP3137503A1 (en) 2014-05-01 2017-03-08 Genentech, Inc. Anti-factor d antibody variants and uses thereof
WO2017075252A1 (en) 2015-10-30 2017-05-04 Genentech, Inc. Anti-factor d antibody variant conjugates and uses thereof
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873A (en) 1846-12-05 Im p rovem ent in loo ms fo r w e avi ng w re-gauz e
US191A (en) 1837-05-08 Machine for facing and dressing stone
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4579827A (en) 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
EP0199141A3 (en) 1985-04-19 1988-07-20 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancer
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
AU597574B2 (en) 1986-03-07 1990-06-07 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4973478A (en) * 1987-07-20 1990-11-27 Allelix Biopharmaceuticals, Inc. Treating inflammation with hepatocyte stimulating factor interferon β2
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
ATE105585T1 (de) 1987-12-21 1994-05-15 Univ Toledo Transformation von keimenden pflanzensamen mit hilfe von agrobacterium.
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
WO1990005537A1 (en) * 1988-11-16 1990-05-31 Brigham And Women's Hospital Inhib, a factor which inhibits cytokine-activated leukocytes
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
EP0586505A1 (en) 1991-05-14 1994-03-16 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
US5756096A (en) 1991-07-25 1998-05-26 Idec Pharmaceuticals Corporation Recombinant antibodies for human therapy
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
DE69232137T2 (de) 1991-11-25 2002-05-29 Enzon Inc Multivalente antigen-bindende proteine
MD1367C2 (ro) 1992-11-13 2000-11-30 Idec Pharmaceuticals Corporation Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
PT616812E (pt) 1993-03-24 2000-04-28 Berlex Biosciences Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro
US5650295A (en) * 1995-06-02 1997-07-22 Human Genone Sciences, Inc. Macrophage migration inhibitory factor-3
US5665701A (en) 1994-11-17 1997-09-09 The Research Foundation Of State University Of New York Platelet membrane glycoprotein F11 and polypeptide fragments thereof
EP0824583A1 (en) * 1995-05-04 1998-02-25 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
AU2582897A (en) 1996-03-15 1997-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
SE9604470D0 (sv) * 1996-12-04 1996-12-04 Tamas Bartfai Konsulting Ab Transmembrane component of tight junction
WO1998040483A2 (en) * 1997-03-14 1998-09-17 Human Genome Sciences, Inc. 28 human secreted proteins
EP0970111A2 (en) * 1997-03-21 2000-01-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
EP1003780A1 (en) * 1997-07-10 2000-05-31 Smithkline Beecham Corporation Human f11 antigen: a cell surface receptor involved in platelet aggregation
JP3868740B2 (ja) * 1998-03-10 2007-01-17 ジェネンテック・インコーポレーテッド 新規なポリペプチド及びそれをコードする核酸
DE69939227D1 (de) * 1998-03-20 2008-09-11 Genentech Inc Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure

Similar Documents

Publication Publication Date Title
JP2004138610A5 (https=)
AU2017378492B2 (en) Variant libraries of the immunological synapse and synthesis thereof
KR100512819B1 (ko) 종양 치료용 조성물 및 방법
US20070048301A1 (en) Compositions and methods for the treatment of immune related diseases
EP1220905A2 (en) Composition and methods for the treatment of immune related diseases
JP2014528714A5 (https=)
JP2002508970A5 (https=)
JP2005027667A5 (https=)
KR20040073586A (ko) 종양 치료용 조성물 및 방법
CN102753579A (zh) 抗钙粘着蛋白抗体
CN1193280A (zh) 用于治疗的cd44基因表达的控制
US7655781B2 (en) Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
US20090148898A1 (en) Human Ron-Related Gene Variant Associated With Cancers
JP2004513614A5 (https=)
WO2003104474A2 (en) Large deletions in human brca1 gene and use thereof
JP2004535161A5 (https=)
JP2008507253A5 (https=)
CA2400638A1 (en) 7 human ovarian and ovarian cancer associated proteins
JP2004515215A5 (https=)
WO1991012272A1 (en) Protein factor
JP2002522021A5 (https=)
WO1999055716A1 (en) A gene associated with nijmegen breakage syndrome, its gene product and methods for their use
CN1646703A (zh) 诊断和治疗与人转酮酶样－1基因过表达有关的增殖异常的组合物和方法
EP1895004A1 (en) Human hippocalcin gene variant associated with cancers
CA2501815A1 (en) Compositions and methods for the treatment of tumor